Get Insight into Future Trends and Developments in the French Generics Market.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c48735) has announced the addition of Datamonitor's new report: Generics in France to their offering. The Generics in France report includes detailed data on market size and segmentation, plus textual tex·tu·al adj. Of, relating to, or conforming to a text. tex  tu·al·ly adv. analysis of the key trends and competitive landscape, demographic information, and descriptions of the leading companies. Scope of this title: * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and leading companies * Includes a five-year forecast of the industry * Supported by the key macroeconomic mac·ro·ec·o·nom·ics n. (used with a sing. verb) The study of the overall aspects and workings of a national economy, such as income, output, and the interrelationship among diverse economic sectors. and demographic data affecting the market Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level research Market Definition The value of the generics market consists of all sales of generics drugs at ex-manufacturers prices. The market does not include consumer healthcare products, nor animal healthcare. We define a generic as a product, which is an officially approved copy of an original product whose patent has expired ex·pire v. ex·pired, ex·pir·ing, ex·pires v.intr. 1. To come to an end; terminate: My membership in the club has expired. 2. , marketed either as a brand or using the generic name generic name n. 1. The official nonproprietary name of a drug, under which it is licensed and identified by the manufacturer. 2. . This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2005 average exchange rates. For the purpose of this report, Europe is deemed to consist of Belgium, France, Germany, Italy, Netherlands, Spain and the UK. Asia-Pacific consists of the Chinese and Japanese markets. The Americas is composed of Canada and the United States The United States and Canada share a unique legal relationship. U.S. law looks northward with a mixture of optimism and cooperation, viewing Canada as an integral part of U.S. economic and environmental policy. . The global market is deemed to be Asia-Pacific, Europe and the Americas. EXECUTIVE SUMMARY Chapter 1 Market overview 1.1 Market Definition 1.2 Research Highlights 1.3 Market Analysis Chapter 2 Market value Chapter 3 Market segmentation Market Segmentation A marketing term referring to the aggregating of prospective buyers into groups (segments) that have common needs and will respond similarly to a marketing action. i Chapter 4 Market segmentation ii Chapter 5 Competitive landscape Chapter 6 Leading companies 6.1 Merck & Co., Inc. 6.2 Novartis AG Novartis AG Swiss pharmaceutical company. It was formed through the 1996 merger of two Swiss firms: Ciba (see Ciba-Geigy) and Sandoz, a chemical company with interests in pharmaceuticals, nutrition, and agriculture. 6.3 Ranbaxy Laboratories Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. It is India's largest pharmaceutical company. It exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. 6.4 Sanofi-Aventis Group 6.5 Servier 6.6 Teva Pharmaceutical Industries Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Chapter 7 Market forecasts 7.1 Market Value Forecast Chapter 8 Macroeconomic indicators Chapter 9 Further reading 9.1 Sources 9.2 Related Research List of Tables Table 1: France Generics Market Value: $ billion, 2000-2004 Table 2: France Generics Market Segmentation I: % Share, by Value, 2004 Table 3: France Generics Market Segmentation II: % Share, by Value, 2004 Table 4: France Generics Market Value Forecast: $ billion, 2004-2009 Table 5: France Size of Population (million) , 2000-2004 Table 6: France GDP GDP (guanosine diphosphate): see guanine. (1995=100), 2000-2004 Table 7: France Inflation, 2000-2004 Table 8: France Exchange Rate, 2000 Companies Mentioned: Merck & Co., Inc. Novartis AG Ranbaxy Laboratories Sanofi-Aventis Group Servier Teva Pharmaceutical Industries For more information visit http://www.researchandmarkets.com/reports/c48735 Source: Datamonitor |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion